7. Segment reporting
The sole operating segment of the Group reflects the internal management structure and is evaluated on an overall basis. Revenue is derived by investing in a portfolio of companies active in the biotechnology industry for the purpose of capital appreciation. The following results correspond to the sole operating segment of investing in companies active in the biotechnology industry.
The geographical analysis of the profit/(loss) before tax is as follows – all income from financial assets are attributed to a country based on the domiciliation of the issuer of the instrument.
Profit/(loss) before tax in CHF 1 000 | 01.01.–30.06.2024 | 01.01.–30.06.2023 | ||
USA | 186 761 | (244 215) | ||
Netherlands | 48 716 | (1 375) | ||
Singapore | 1 700 | (14 434) | ||
Switzerland | (3 158) | 8 598 | ||
Canada | (6 505) | 696 | ||
British Virgin Islands | (9 557) | – | ||
Curaçao | (17 098) | (18 391) | ||
Great Britain | (27 408) | 1 818 | ||
173 450 | (267 303) |